The First Symposium on Human Papillomavirus Vaccination in the Asia-Pacific and Middle East Regions
		welcome address
Time Title Speaker 56 Kbps 300 Kbps 0830-0845 Regional Advisor, WHO Western Pacific Region Dr. YANG Baoping 0845-0900 Director, Korea CDC Dr. LEE Jong-koo 0900-0915 Director-General, IVI Dr. John Clemens 0915-0930 Former Director-General, Indian Council of Medical Research Dr. N.K. Ganguly
		Session 1: Human Papillomavirus (HPV) and HPV-associated diseases
Time Title Speaker 56 Kbps 300 Kbps 0935-0955 Natual history of infection, epidemiology of infection and disease F. Xavier Bosch 0955-1015 HPV and HPV-associated diseases Suzanne Garland 1035-1055 Diagnosis and surveillance of HPV disease: cervical cancer screening-old and new technologies Sun Kuie Tay 1055-1115 Cervical cancer screening programs and implications of HPV vaccination Silvia de Sanjose 1115-1135 Global burden of HPV disease with emphasis on the Asia-Pacific and Middle Eastern regions Jong Sup Park 1135-1220 Burden of HPV disease: Country-specific perspective - in China (15 mins.) - in India (15 mins.) - in the Middle East and North Africa (15 mins.)   Youlin Qiao Neerja Bhatla Muhieddine Seoud     1320-1430 Roundtable discussion on the significance of HPV disease Do we have enough data on HPV? Are there still gaps in our knowledge on HPV? Chair: F. Xavier Bosch
		Session 2: HPV Vaccines and Global Recommendations
Time Title Speaker 56 Kbps 300 Kbps 1430-1450 Vaccine efficacy, effectiveness and safety of HPV vaccines Xavier Castellsague 1450-1510 Vaccine demonstration projects in India, Peru, Uganda, and Vietnam Scott LaMontagne 1510-1530 Overview of SAGE Recommendations and WHO Position Paper on HPV Vaccines Linda Eckert 1600-1630 Existing HPV vaccines - Glaxosmithkline (15 minutes) - Merck (15 minutes)   Hugues Bogaerts Randall Hyer
		Session 3: Vaccine Introduction Decision-making Tools, and Financing of HPV Vaccines
Time Title Speaker 56 Kbps 300 Kbps 0900-0930 HPV Vaccine Introduction: Decision-making tools Linda Eckert 0930-1000 Financing HPV vaccine: the role of the GAVI Alliance GAVI 1020-1050 Modelling the Cost-Effectiveness of HPV Vaccination: Evidence from High-Income Countries and Considerations for Low- and Middle-Income Countries L Connelly 1050-1200 Roundtable discussion: Challenges and solutions for financing HPV vaccines in middle income countries Chair: Aisha Jumaan
		Session 4: Country Experiences with HPV Vaccine Introduction
Time Title Speaker 56 Kbps 300 Kbps 1300-1320 United Kingdom P MacDonald 1320-1340 Australia Julia Brotherton 1340-1400 Fiji Fiona Russell/ Frances Bingwor 1400-1420 Taiwan Li-Min Huang 1420-1440 Turkey Murat Tuncer 1440-1500 Performance monitoring & evaluation of HPV vaccines: The National HPV Vaccination Program Register, Australia Dorota Gertig
		Session 5: Communication and Advocacy for HPV vaccine introduction
Time Title Speaker 56 Kbps 300 Kbps 1520-1540 Socio-cultural issues for development of HPV vaccination and communication strategies Aisha Jumaan 1540-1600 Raising awareness about HPV & communication strategies for HPV vaccines Cecilia Llave 1600-1700 Roundtable discussion: Advocacy for HPV vaccine introduction in countries of the Asia Pacific and Middle East Regions Chair: Y Baoping 1700-1740 Concluding remarks: - Summary of the Symposium - Call to action for HPV vaccine introduction in Asia-Pacific and Middle East Regions - Next steps Susan Hariri Suzanne Garland F. Xavier Bosch